期刊文献+

血清甲胎蛋白在肿瘤鉴别诊断中的意义 被引量:5

Significance of maternal serm alpha-fetoprotein in differential diagnosis of tmor
下载PDF
导出
摘要 主要阐述血清甲胎蛋白(AFP)在肿瘤诊断中的鉴别意义。说明AFP对肝细胞癌的临床诊断价值为各种诊断方法中专一性仅次于病理检查的诊断方法,为目前最好的早期诊断方法之一。对年轻男性,前纵隔肿块伴AFP或/和HCG水平升高者,可诊断为纵隔非精原细胞瘤。睾丸癌AFP检测的价值在于患者的临床症状和其他的诊断程序相结合时,诊断非精原细胞瘤睾丸癌。AFP是开放性神经管缺陷及唐氏综合征的标记物。 To state significance of maternal serum alpha-fetoprotein(AFP) in the differential diagnosis of tumor. Clinical application had proved that the AFP was the best diagnostic method secondary to pathological examination for hepatocellular carcinoma(HCC), which was one of the best early diagnostic methods. For young men, the former mediastinal mass with increasing AFP and/or HCG levels can be diagnosed with mediastinal seminoma, generally do not need regular biopsy confirmed. The value of testicular cancer AFP detection is that the combination of clinical symptoms and other diagnostic procedures help to diagnose non seminoma testicular cancer. AFP is an open neural tube defects and markers for down syndrome.
作者 邢建军 苗阳
出处 《中国实用医药》 2014年第20期242-243,共2页 China Practical Medicine
关键词 血清甲胎蛋白 肝癌 纵隔恶性生殖细胞瘤 睾丸癌 Maternal serum alpha-fetoprotein Liver cancer Mediastinal malignant germ cell tumor Testicular cancer
  • 相关文献

参考文献9

  • 1Fateh-MoghadamA.肿瘤标志的合理应用.万文徽,译.北京:北京大学医学出版社.2007:33.
  • 2吉岡幹博,井上宣也染田仁,野口麻希子,等.S-1/CDDP併用化学療法が奏効し切除し得たAFP産生胃痛の1例.癌と化学療法,2011,38(1):105-108.
  • 3ChabnerBA,LynchTJ,LongoDL.哈里森肿瘤学手册.李小梅.译.北京:人民军医出版社,2010:398,444.
  • 4汤钊猷.现代肿瘤学.第3版.上海:复旦大学出版社,2011:1419-1423.
  • 5陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2005,1469-1471.
  • 6Na K, Jeong SK, Lee MJ, et al. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients. International Journal of Cancer, 2013,133(2):408-415.
  • 7储大同.当代肿瘤内科治疗方案评价.第3版.北京:北京大学医学出版社,2011:612.
  • 8JimCassidy,DonaldBissett,RoyAJSpenceOBE著.季加孚,沈琳,寿成超,等主译.牛津临床肿瘤手册.北京:人民卫生出版社,2006:119.128.
  • 9张旸,翟妍,刘浩,李艳芳,路军丽,张震宇.中孕期母血清学标志物与不良妊娠结局的相关性分析[J].中华医学杂志,2014,94(5):379-381. 被引量:23

二级参考文献11

  • 1Sayin NC,Canda MT,Ahmet N. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns[J].{H}Archives Of Gynecology and Obstetrics,2008.47-53.
  • 2Huang T,Hoffman B,Meschino W. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome[J].{H}Prenatal Diagnosis,2010.471-477.
  • 3Lao MR,Calhoun BC,Bracero LA. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population[J].{H}Journal of Medical Screening,2009.55-59.
  • 4乐杰.妇产科学[M]7版.北京:人民卫生出版社,200883-137.
  • 5Van Ravenswaaij R,Tesselaar-van der Goot M,de Wolf S. First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome[J].{H}Prenatal Diagnosis,2011.50-57.
  • 6Bogart MH,Pandian MR,Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities[J].{H}Prenatal Diagnosis,1987.623-630.
  • 7Olsen RN,Woelkers D,Dunsmoor-Su R. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia[J].{H}AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,2012.228.e1-228.e7.
  • 8Jelliffe-Pawlowski LL,Baer RJ,Currier RJ. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies[J].{H}Prenatal Diagnosis,2010.727-733.
  • 9Gagnon A,Wilson RD,Audibert F. Obstetrical complications associated with abnormal maternal serum markers analytes[J].J Obstet Gynaecol Can,2008.918-949.
  • 10Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin[J].{H}Reproductive Biology and Endocrinology,2009.8.

共引文献198

同被引文献40

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部